Is 20/20 Biolabs Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: AIDX) stock is to Strong Buy AIDX stock.
Out of 1 analyst, 1 (100%) are recommending AIDX as a Strong Buy, 0 (0%) are recommending AIDX as a Buy, 0 (0%) are recommending AIDX as a Hold, 0 (0%) are recommending AIDX as a Sell, and 0 (0%) are recommending AIDX as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year AIDX price target, the average AIDX price target is $5.00, with the highest AIDX stock price forecast at $5.00 and the lowest AIDX stock price forecast at $5.00.
The Wall Street analyst predicted that 20/20 Biolabs's share price could reach $5.00 by May 11, 2027. The average 20/20 Biolabs stock price prediction forecasts a potential upside of 314.94% from the current AIDX share price of $1.21.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.